PHDG yields 2.09% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, PHDG + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PHDG + JNJ for your $10,000?
The Invesco S&P 500 Downside Hedged ETF (Fund) is an actively managed exchange-traded fund (ETF) that seeks to achieve positive total returns in rising or falling markets that are not directly correlated to broad equity or fixed-income market returns. The Fund seeks to achieve its investment objective by allocating its assets among components of the S&P 500 Dynamic VEQTOR Index (Benchmark). The Benchmark is composed of three types of components: (i) equity, represented by the S&P 500 Index; (ii) volatility hedge, represented by the S&P 500 VIX Short-Term Futures Index; and (iii) cash. The Benchmark is designed to measure the performance of the broad equity markets with an implied volatility1 hedge. The Fund allows investors to receive exposure to the equity and volatility of the S&P 500 Index in a dynamic framework. The Fund allows investors to receive exposure to the equity and volatility of the S&P 500 Index in a dynamic framework.
Full PHDG Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.